A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition

NCT01533766 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Parent

Interventions

DRUG: CombiflexOmega
DRUG: SmofKabiven

Sponsor

JW Life Science